MEDP:NSD-Medpace Holdings Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 294.89

Change

0.00 (0.00)%

Market Cap

USD 8.65B

Volume

0.27M

Analyst Target

USD 118.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-24 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
IDXX IDEXX Laboratories Inc

N/A

USD 37.95B
NTRA Natera Inc

N/A

USD 20.66B
ILMN Illumina Inc

N/A

USD 11.99B
ICLR ICON PLC

N/A

USD 11.79B
EXAS EXACT Sciences Corporation

N/A

USD 8.44B
GH Guardant Health Inc

N/A

USD 5.04B
RDNT RadNet Inc

N/A

USD 3.72B
SHC Sotera Health Co

N/A

USD 3.45B
VCYT Veracyte Inc

N/A

USD 2.51B
WGS GeneDx Holdings Corp.

N/A

USD 1.95B

ETFs Containing MEDP

UIQI:F UBS (Irl) Fund Solutions .. 96.30 % 0.00 %

N/A

USD 0.31B
AJEUAS:SW UBS (Irl) Fund Solutions .. 96.30 % 0.00 %

N/A

N/A
DXSH:XETRA Xtrackers - Stoxx Europe .. 4.82 % 0.00 %

N/A

USD 0.03B
S6EW:PA Ossiam Stoxx Europe 600 E.. 4.65 % 0.00 %

N/A

USD 0.11B
S6EW:SW 4.65 % 0.00 %

N/A

N/A
EL4G:XETRA Deka EURO STOXX Select Di.. 3.94 % 0.00 %

N/A

USD 0.17B
C051:XETRA Amundi Euro Stoxx Select .. 3.94 % 0.00 %

N/A

USD 0.06B
EXSG:XETRA iShares EURO STOXX Select.. 3.87 % 0.00 %

N/A

USD 0.64B
XCLN:CA iShares Global Clean Ener.. 3.80 % 0.00 %

N/A

CAD 8.90M
INRE:PA iShares Global Clean Ener.. 3.79 % 0.00 %

N/A

N/A
VCLN Virtus Duff & Phelps Clea.. 3.78 % 0.00 %

N/A

USD 5.91M
INRG:SW iShares Global Clean Ener.. 3.73 % 0.00 %

N/A

USD 1.85B
AMID Argent Mid Cap ETF 3.71 % 0.00 %

N/A

N/A
EUDV:PA SSgA SPDR ETFs Europe I P.. 3.49 % 0.00 %

N/A

USD 1.03B
EUDV:SW SPDR® S&P Euro Dividend .. 3.48 % 0.00 %

N/A

N/A
HYDRO:PA BNP Paribas Easy ECPI Glo.. 2.98 % 0.00 %

N/A

N/A
FNRG:LSE 2.84 % 0.00 %

N/A

N/A
XS6R:XETRA Xtrackers MSCI Europe Uti.. 2.81 % 0.00 %

N/A

N/A
REUSE:PA BNP Paribas Easy ECPI Cir.. 2.49 % 0.00 %

N/A

N/A
NRJ:PA Multi Units France - Lyxo.. 2.44 % 0.00 %

N/A

USD 0.56B
STUX:SW SPDR® MSCI Europe Utilit.. 2.40 % 0.00 %

N/A

USD 0.16B
NRJL:LSE Lyxor MSCI New Energy ESG.. 2.39 % 0.00 %

N/A

USD 0.56B
STU:PA SPDR® MSCI Europe Utilit.. 2.38 % 0.00 %

N/A

USD 0.16B
RENW:LSE L&G Clean Energy UCITS ET.. 2.07 % 0.00 %

N/A

USD 0.19B
WDIV SPDR® S&P Global Dividen.. 1.48 % 0.40 %

N/A

USD 0.20B
QSML:AU VanEck MSCI International.. 1.45 % 0.00 %

N/A

N/A
LDEU:LSE L&G Quality Equity Divide.. 1.15 % 0.00 %

N/A

USD 0.07B
LGGE:XETRA L&G Quality Equity Divide.. 1.15 % 0.00 %

N/A

USD 0.03B
ICLN iShares Global Clean Ener.. 0.00 % 0.46 %

N/A

USD 1.31B
RFG Invesco S&P MidCap 400® .. 0.00 % 0.35 %

N/A

N/A
JSMD Janus Henderson Small/Mid.. 0.00 % 0.50 %

N/A

USD 0.44B
FID First Trust Intl Multi-As.. 0.00 % 0.69 %

N/A

USD 0.10B
SMLF iShares MSCI USA Small-Ca.. 0.00 % 0.30 %

N/A

N/A
INRG:LSE iShares Global Clean Ener.. 0.00 % 0.00 %

N/A

N/A
L6EW:LSE Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

N/A

USD 0.11B
LCPE:LSE Ossiam Shiller Barclays C.. 0.00 % 0.00 %

N/A

USD 0.14B
S6EW:LSE Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

N/A

N/A
JELS:LSE 0.00 % 0.00 %

N/A

N/A
UTIL:LSE SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

N/A

USD 0.16B
XS6R:LSE Xtrackers MSCI Europe Uti.. 0.00 % 0.00 %

N/A

USD 0.03B
IQQH:F iShares Global Clean Ener.. 0.00 % 0.00 %

N/A

N/A
OSX6:F Ossiam Lux - Ossiam Stoxx.. 0.00 % 0.00 %

N/A

N/A
SPYU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
SPYW:F SPDR S&P Euro Dividend Ar.. 0.00 % 0.00 %

N/A

N/A
IQQH:XETRA iShares Global Clean Ener.. 0.00 % 0.00 %

N/A

N/A
OSX6:XETRA Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

N/A

N/A
SPYU:XETRA SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

N/A

N/A
ZCLN:CA BMO Clean Energy Index ET.. 0.00 % 0.00 %

N/A

CAD 0.05B
IBBJ 0.00 % 0.00 %

N/A

N/A
RENG:LSE L&G Clean Energy UCITS ET.. 0.00 % 0.00 %

N/A

USD 0.19B

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.24% 64% D 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.24% 64% D 41% F
Trailing 12 Months  
Capital Gain -24.49% 49% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -24.49% 49% F 33% F
Trailing 5 Years  
Capital Gain 219.91% 93% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 219.91% 93% A 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 33.14% 80% B- 85% B
Dividend Return 33.14% 80% B- 85% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 38.56% 68% D+ 46% F
Risk Adjusted Return 85.94% 100% F 94% A
Market Capitalization 8.65B 89% A- 92% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.